Follicle-Stimulating Hormone-Secreting Pituitary Adenoma Inducing Spontaneous Ovarian Hyperstimulation Syndrome, Treatment Using In Vitro Fertilization and Embryo Transfer: A Case Report
- PMID: 34248835
- PMCID: PMC8264655
- DOI: 10.3389/fendo.2021.621456
Follicle-Stimulating Hormone-Secreting Pituitary Adenoma Inducing Spontaneous Ovarian Hyperstimulation Syndrome, Treatment Using In Vitro Fertilization and Embryo Transfer: A Case Report
Abstract
Objective: To describe the management of a patient with a pituitary adenoma secreting follicle-stimulating hormone (FSH) associated with spontaneous ovarian hyperstimulation syndrome (sOHSS) who was treated with in vitro fertilization and embryo transfer (IVF-ET).
Methods: We report a clinical case of a woman of reproductive age with menstrual irregularity, infertility and ovarian hyperstimulation due to recurrent pituitary adenoma secreting FSH, which persisted after transsphenoidal surgery.She underwent the diagnosis by magnetic resonance imaging (MRI) and laboratory tests,and finally she was treated with IVF-ET.
Results: The patient was plagued by a recurrent pituitary adenoma for many years and tried various treatments. After complete transsphenoidal surgery, sOHSS decreased, as shown by a reduction in oestradiol levels and an improvement in the ultrasonography parameters; however, secondary amenorrhea occurred. Finally, pregnancy was achieved through IVF-ET and the symptoms of ovarian hyperstimulation were relieved.
Conclusions: IVF-ET was found to be effective for the treatment of recurrent pituitary adenoma, thus representing a therapeutic option that should be taken into consideration in such cases.
Keywords: FSH-secreting pituitary adenoma; IVF-ET; endocrine disorders; spontaneous ovarian hyperstimulation syndrome; transsphenoidal surgery.
Copyright © 2021 Du, Zhang, Wang, Yu, Li and Guan.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Follicle-stimulating hormone-secreting pituitary adenoma manifesting as recurrent ovarian cysts in a young woman--latent risk of unidentified ovarian hyperstimulation: a case report.BMC Res Notes. 2013 Oct 11;6:408. doi: 10.1186/1756-0500-6-408. BMC Res Notes. 2013. PMID: 24119690 Free PMC article.
-
A pituitary adenoma secreting follicle-stimulating hormone with ovarian hyperstimulation: treatment using a gonadotropin-releasing hormone antagonist.Fertil Steril. 2012 Jan;97(1):231-4. doi: 10.1016/j.fertnstert.2011.10.015. Epub 2011 Nov 25. Fertil Steril. 2012. PMID: 22118994
-
Spontaneous ovarian hyperstimulation caused by a follicle-stimulating hormone-secreting pituitary adenoma.Fertil Steril. 2005 Jan;83(1):208-10. doi: 10.1016/j.fertnstert.2004.06.061. Fertil Steril. 2005. PMID: 15652911
-
Functioning gonadotroph adenoma with severe ovarian hyperstimulation syndrome: A new emergency in pituitary adenoma surgery? Surgical considerations and literature review.Ann Endocrinol (Paris). 2019 Apr;80(2):122-127. doi: 10.1016/j.ando.2018.11.007. Epub 2019 Feb 7. Ann Endocrinol (Paris). 2019. PMID: 30825998 Review.
-
Ovarian hyperstimulation without elevated serum estradiol associated with pure follicle-stimulating hormone-secreting pituitary adenoma.J Clin Endocrinol Metab. 2001 Aug;86(8):3635-40. doi: 10.1210/jcem.86.8.7766. J Clin Endocrinol Metab. 2001. PMID: 11502789 Review.
Cited by
-
Prognostic Factors for Invasiveness and Recurrence of Pituitary Adenomas: A Series of 94 Patients.Diagnostics (Basel). 2022 Oct 5;12(10):2413. doi: 10.3390/diagnostics12102413. Diagnostics (Basel). 2022. PMID: 36292101 Free PMC article.
-
Updating the Landscape for Functioning Gonadotroph Tumors.Medicina (Kaunas). 2022 Aug 8;58(8):1071. doi: 10.3390/medicina58081071. Medicina (Kaunas). 2022. PMID: 36013538 Free PMC article. Review.
-
Optimal waiting period for frozen embryo transfer after hysteroscopic polypectomy: A propensity score matching analysis.Front Endocrinol (Lausanne). 2022 Sep 30;13:986809. doi: 10.3389/fendo.2022.986809. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36246905 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical